4//SEC Filing
Novack David F 4
Accession 0001029142-25-000037
CIK 0001029142other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:13 PM ET
Size
15.0 KB
Accession
0001029142-25-000037
Insider Transaction Report
Form 4
Novack David F
President & COO
Transactions
- Exercise/Conversion
Common Stock
2025-02-13+26,500→ 54,156 total - Tax Payment
Common Stock
2025-02-13$12.69/sh−12,480$158,371→ 42,907 total - Award
Restricted Stock Unit
2025-02-13+26,500→ 26,500 total→ Common Stock (26,500 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-13−26,500→ 0 total→ Common Stock (26,500 underlying) - Award
Stock Option (Right to Buy)
2025-02-13+93,000→ 93,000 totalExercise: $12.69Exp: 2032-02-13→ Common Stock (93,000 underlying) - Award
Restricted Stock Unit
2025-02-13+56,364→ 56,364 total→ Common Stock (56,364 underlying)
Footnotes (5)
- [F1]Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.
- [F2]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
- [F3]Includes 1,231 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 14, 2025.
- [F4]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 13, 2025, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
- [F5]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 13, 2025.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001573072
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 5:13 PM ET
- Size
- 15.0 KB